Prognostic impact of tace combined with sorafenib or lenvatinib followed by regorafenib in recurrent hepatocellular carcinoma after liver transplantation: a retrospective study by Zhao-dan Ye, Meng-chen Song, Al-Kalei AMA, Li Zhuang, Yan Zhang, Sheng-li Ye, He-miao Shi, Si-yi Zhong, Dan Zhu, Guo-hong Cao, Jing-feng Zhang

Get full text